305895
Challenges to Viral Suppression among Young Adults in a US Outpatient Clinic
Methods: As standard of care, patients presenting for care completed behavioral and psychological distress assessments annually. Sexually transmitted infection (STI) tests are conducted annually and by need. Data were abstracted from medical charts in 2013 among patients aged 18 and 30 years. Bivariate analyses were conducted to identify factors related to viral suppression and STI attainment.
Results: A total of 335 individuals presented for care during the 12 month period. The majority of the sample was African American and had a mean age of 25.1. Nearly all had current prescriptions antiretroviral therapy (ART); among those receiving ARTs, 72.8% were virally suppressed. Women and individuals who expressed psychological distress symptoms more often had unsuppressed viral loads. Nearly 60% reported condom use at last sex. One-third of this sample had at least 1 STI diagnosis within the last year, with 193 total STI events. Of the 102 individuals that had an STI, 47% had > two. Having two or more STIs was significantly associated with race, gender, and having two or more partners.
Conclusions: These findings identify challenges that young adults experience as they manage their HIV care. Increased prevention efforts need to incorporate preventing additional STIs, manage psychological distress, and address race and gender in the clinic setting.
Learning Areas:
Conduct evaluation related to programs, research, and other areas of practiceProgram planning
Public health or related research
Social and behavioral sciences
Learning Objectives:
Describe challenges that youth experience in managing their HIV.
Keyword(s): HIV Risk Behavior, Adolescents
Qualified on the content I am responsible for because: Graduate research assistant working with people living with HIV. Currently working on a project funded by the NIAAA.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.